A total of 18 enrollments in one month!!
On 28-February-2013, Henry Ford Heath System randomized the 327th patient in the CLEAR-III trial. In September-2012, the CLEAR-III team set the bar high with 17 enrollments. But, it took Just 5 months to beat that amazing record and set the bar even higher to 18 enrollments for the month of February.
Composed and sung in Waikiki on 05-February-2013 by Keith Gregson while attending the International Stroke Conference. It is set to an old cajun fiddle tune and dedicated to Dan Hanley and members of the CLEAR and MISTIE teams at JHU, Baltimore, Maryland. Keith is the spouse of Barbara Gregson, who manages the STICH-II trial and is a member of the CLEAR steering committee.
In 2013 we took a little trip to a famous city on the mighty Mississip
To watch Ray Lewis and his Superbowl machine meet the 49ers in the ‘town’ of New Orleans
Aloha Friends! In just a few short days, we will be in sunny Honolulu at the International Stroke Conference. In addition to our CLEAR III Annual Meeting on Tuesday night, we have many other exciting programs and presentations during the conference. Continue reading for details on all events. We hope to see you there!
Clear-III Hits 300 Landmark
We are proud to announce that on January 6, 2013, at approximately 18:07 Henry Ford Health System enrolled the 300th patient in CLEAR-III. This landmark achievement could not have been accomplished without the great dedication and commitment from everyone involved in the CLEAR trial since day one. A big thank you from everyone at BIOS to all of YOU who made this happen! We are confident that with your help and commitment we will continue to combat hemorrhagic stroke one patient at a time. This is a great milestone for our trial, with one more giant step towards the finish line at 500 patients. We look forward to celebrating future millstones with you. Thank you!!!!!
The Germans are back!!!
After being on hold for nine months due to radiation issues, team Germany is back in action in the CLEAR III–World Cup tournament. Right after IRB approval team Germany burst into action with randomizing four patients within fourteen days. University of Mainz kick started this extraordinary run with randomizing their first patient on November 7th. University of Heidelberg and Leipzig followed by randomizing patients on the 8th and 19th of November. The surge continued with Mainz randomizing again to bring total enrolments to four patients this month.
